Pharmaceutical Research and Development Services

An integrated pharmaceutical R&D partner provides coordinated support across multiple disciplines, including formulation and analytical support, regulatory strategy, quality, and lifecycle planning. Rather than working in silos, these functions are aligned from the start to help teams anticipate downstream requirements, reduce rework, and make more informed decisions at each stage of development. 

At Kiel Laboratories, this integrated approach is grounded in real-world experience. The team works across strategy, consulting, and execution to guide programs from early planning through approval and beyond.  

The pharmaceutical product development process generally begins with concept evaluation and feasibility assessment, followed by drug product development, including formulation development and analytical testing. Early in development, teams should also define a regulatory strategy to ensure downstream requirements are understood. They may then conduct required studies to support regulatory filings and enable submissions such as NDAs or ANDAs. Throughout development, quality systems and documentation are established to ensure compliance and readiness for regulatory review. After submission and FDA review, approval may be granted, followed by ongoing post-market commitments and lifecycle management to maintain and extend the product’s value. 

Kiel Laboratories provides end-to-end support that adapts to your program’s stage and needs: 

• Strategy: Defining development pathways, regulatory and intellectual property considerations, and risk mitigation plans early 
• Consulting: Identifying gaps, addressing technical and regulatory challenges, and guiding key decisions 
• Technical execution: Supporting formulation and analytical development,  and scale-up and manufacturing readiness 
• Regulatory support: Managing submissions, FDA interactions, and post-market requirements 
• Quality assurance: Building scalable systems, conducting audits, and ensuring cGMP compliance 
• Lifecycle management: Identifying opportunities for reformulation, new indications, or market expansion 

Kiel helps reduce risk by identifying potential issues early, before they lead to costly delays or rework. This includes evaluating regulatory pathways, anticipating FDA expectations, assessing formulation feasibility, and ensuring quality systems are aligned with development stage. By integrating technical, regulatory, and quality expertise, Kiel minimizes disconnects between functions and helps teams make decisions that hold up later in the process, ultimately improving timelines and outcomes. 

These functions are closely interconnected, and alignment between them is critical to successful development: 

• Drug product development: Establishes the formulation and technical foundation of the product 
• Regulatory strategy: Defines the appropriate approval pathway and ensures development aligns with FDA expectations 
• Quality assurance: Builds systems and documentation to support compliance and inspection readiness 
• Lifecycle management: Uses technical, regulatory, and IP insights to extend product value post-approval through improvements and new opportunities

You can explore Kiel Laboratories’ Resource Center for insights on pharmaceutical development strategy, regulatory considerations, and common challenges across the product lifecycle. For guidance specific to your program, connecting directly with Kiel’s experts can provide tailored recommendations based on your product, timeline, and regulatory goals.